MARKET

HEPA

HEPA

Hepion Pharmaceuticals Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.74
+0.20
+3.61%
After Hours: 5.72 -0.02 -0.35% 19:53 01/17 EST
OPEN
5.54
PREV CLOSE
5.54
HIGH
5.90
LOW
5.49
VOLUME
231.76K
TURNOVER
--
52 WEEK HIGH
27.30
52 WEEK LOW
2.000
MARKET CAP
19.82M
P/E (TTM)
-0.2459
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HEPA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HEPA News

  • Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
  • ACCESSWIRE.01/08 21:15
  • APA, ADXS among premarket gainers
  • Seeking Alpha - Article.01/07 14:14
  • Hepion Pharma up 15% premarket potential of CRV431 in NASH
  • Seeking Alpha - Article.01/07 13:08
  • The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
  • Benzinga.01/07 12:57

More

Industry

Biotechnology & Medical Research
-0.10%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About HEPA

Hepion Pharmaceuticals Inc., formerly ContraVir Pharmaceuticals, Inc., is a clinical stage biopharmaceutical company. The Company is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection. Its lead oral drug candidate, CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. CRV431 is also being developed for viral hepatitis-induced liver disease. CRV431 targets multiple biochemical pathways involved in the progression of liver disease.
More

Webull offers Hepion Pharmaceuticals Inc (HEPA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.